Skip to content
Home/Companies/Pharma/Cambrex
Cambrex

Cambrex

Pharma·USA·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Cambrex?

Cambrex is an American Pharma company, currently owned by Permira since 2019.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Permira
Investor
Permira
Permira VII · 2019 · Buyout

Key facts

HQUSA
SectorPharma
Websitewww.cambrex.com

More from Permira VII

Other portfolio companies in the same fund.

Kedrion
Active
PharmaItaly· 2022
McAfee
McAfee
Active
CybersecurityUS· 2022
Mimecast
Mimecast
Active
CybersecurityUK· 2022
Boats Group
Active
E-commerceUS· 2021
Golden Goose
Golden Goose
Exited 2025
ConsumerItaly· 2020
to HSG (HongShan)
Lytx
Lytx
Active
AI/MLUS· 2020

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Cambrex?

Cambrex is currently owned by Permira, through Permira VII, since 2019.

When did Permira acquire Cambrex?

Permira acquired Cambrex in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue